Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Envoy Medical, Inc. (COCH : NSDQ)

• Company Description    Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota. Number of Employees: 42

• Price / Volume Information    Yesterday's Closing Price: $1.55 Daily Weekly Monthly 20 Day Moving Average: 22,702 shares Shares Outstanding: 21.33 (millions) Market Capitalization: $33.06 (millions) Beta: 2.22 52 Week High: $3.99 52 Week Low: $1.21 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 13.14% 8.03% 12 Week 15.67% -2.38% Year To Date 8.39% 1.84%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4875 WHITE BEAR PARKWAY - WHITE BEAR LAKE,MN 55110 USA ph: 877-900-3277 fax: - scotta@coreir.com http://www.envoymedical.com

• General Corporate Information    Officers Brent T. Lucas - Chief Executive Officer David R. Wells - Chief Financial Officer Charles R. Brynelsen - Director Glen A. Taylor - Director Mona Patel - Director Peer Information Envoy Medical, Inc. (ABMD) Envoy Medical, Inc. (DMDS) Envoy Medical, Inc. (CPWY.) Envoy Medical, Inc. (EQUR) Envoy Medical, Inc. (ECIA) Envoy Medical, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 29415V109 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/11/25 Share - Related Items Shares Outstanding: 21.33 Most Recent Split Date: (:1) Beta: 2.22 Market Capitalization: $33.06 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.31 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.18 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 155.93 EPS Growth vs. Year Ago Period: 9.38% vs. Previous Quarter: 35.56% Sales Growth vs. Year Ago Period: -22.03% vs. Previous Quarter: 9.52% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - -237.44 12/31/24 - -264.03 Current Ratio 06/30/25 - - 03/31/25 - 1.09 12/31/24 - 1.24 Quick Ratio 06/30/25 - - 03/31/25 - 0.88 12/31/24 - 1.02 Operating Margin 06/30/25 - - 03/31/25 - -10,656.13 12/31/24 - -10,605.78 Net Margin 06/30/25 - - 03/31/25 - -10,656.13 12/31/24 - -10,605.78 Pre-Tax Margin 06/30/25 - - 03/31/25 - -9,208.96 12/31/24 - -9,242.22 Book Value 06/30/25 - - 03/31/25 - -1.14 12/31/24 - -0.88 Inventory Turnover 06/30/25 - - 03/31/25 - 0.49 12/31/24 - 0.46 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©